The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis

Evelina Ferrantelli; Georgios Liappas; Marc Vila Cuenca; Eelco D. Keuning; Thomas L. Foster; Marc G. Vervloet; Manuel Lopez-Cabrera; Robert H. J. Beelen

doi:10.1016/j.kint.2015.12.005

The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis

Evelina Ferrantelli, Georgios Liappas, Marc Vila Cuenca, Eelco D. Keuning, Thomas L. Foster, Marc G. Vervloet, Manuel Lopez-Cabrera, Robert H. J. Beelen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	625-635
Journal	Kidney International
Volume	89
Issue number	3
DOIs	https://doi.org/10.1016/j.kint.2015.12.005
Publication status	Published - Mar 2016

Access to Document

10.1016/j.kint.2015.12.005

Cite this

Ferrantelli, E., Liappas, G., Cuenca, M. V., Keuning, E. D., Foster, T. L., Vervloet, M. G., ... Beelen, R. H. J. (2016). The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis. Kidney International, 89(3), 625-635. https://doi.org/10.1016/j.kint.2015.12.005

@article{959a30a7e96c410f942a74a1bea32409,

title = "The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis",

keywords = "Ala-Gln, fibrosis, IL-17, peritoneal dialysis, peritoneal membrane",

author = "Evelina Ferrantelli and Georgios Liappas and Cuenca, {Marc Vila} and Keuning, {Eelco D.} and Foster, {Thomas L.} and Vervloet, {Marc G.} and Manuel Lopez-Cabrera and Beelen, {Robert H. J.}",

year = "2016",

month = "3",

doi = "10.1016/j.kint.2015.12.005",

language = "English",

volume = "89",

pages = "625--635",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "3",

}

The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis. / Ferrantelli, Evelina; Liappas, Georgios; Cuenca, Marc Vila; Keuning, Eelco D.; Foster, Thomas L.; Vervloet, Marc G.; Lopez-Cabrera, Manuel; Beelen, Robert H. J.

In: Kidney International, Vol. 89, No. 3, 03.2016, p. 625-635.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis

AU - Ferrantelli, Evelina

AU - Liappas, Georgios

AU - Cuenca, Marc Vila

AU - Keuning, Eelco D.

AU - Foster, Thomas L.

AU - Vervloet, Marc G.

AU - Lopez-Cabrera, Manuel

AU - Beelen, Robert H. J.

PY - 2016/3

Y1 - 2016/3

KW - Ala-Gln

KW - fibrosis

KW - IL-17

KW - peritoneal dialysis

KW - peritoneal membrane

U2 - 10.1016/j.kint.2015.12.005

DO - 10.1016/j.kint.2015.12.005

M3 - Article

C2 - 26880457

VL - 89

SP - 625

EP - 635

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 3

ER -